Great Debates in HIV Care

Event Information

Share this event

Date and Time



Marriott Marquis Washington, DC

901 Massachusetts Ave NW

Liberty Salons IJKL; Meeting Level 4

Washington, DC 20001

View Map

Event description


This program is intended for IDWeek™ 2019 attendees only.

Activity Chair

Richard A. Elion, MD
Director of Clinical Research
Washington Health Institute
Clinical Professor of Medicine
George Washington University School of Medicine
Washington, DC


Grace A. McComsey, MD, FIDSA
Vice President of Research and Associate Chief Scientific Officer University Hospitals Health System
Director, University Hospitals Clinical Research Center
Director, Dahms Clinical Research Unit
John Kennell Endowed Chair
Chief, Pediatric Infectious Diseases and Rheumatology
Professor of Pediatrics and Medicine
Case Western Reserve University
Cleveland, OH

Graeme J. Moyle, MD, MBBS, DipGUM
Director of HIV Research Strategy
Chelsea and Westminster Hospital
London, United Kingdom

Babafemi O. Taiwo, MBBS
Professor of Medicine
Chief, Division of Infectious Diseases
Northwestern University Feinberg School of Medicine
Chicago, IL

David A. Wohl, MD
Professor of Medicine
Division of Infectious Diseases
University of North Carolina at Chapel Hill School of Medicine
Chapel Hill, NC


This CME activity, "Great Debates in HIV Care," will feature discussion and debate among worldwide experts from a practical and clinically relevant perspective about critical and potentially controversial issues in the care of patients with HIV. Antiretroviral therapy (ART) has improved dramatically over the past decade. This progress has yielded more treatment choices for clinicians and patients but also adds greater complexity to the already diverse field of HIV. In this interactive, case-based program, expert faculty will provide guidance on how to incorporate new treatment strategies into clinical practice and will discuss various aspects of HIV management, including selecting an initial antiretroviral regimen, clarifying the differences in tenofovir alafenamide and tenofovir disoproxil fumarate in antiretroviral therapeutic regimens, considering cardiovascular disease and diabetes in the management of patients with HIV, switching ART, and managing treatment in women.


10:30 AM
Registration and Lunch

11:00 AM
Introduction and Pretest
Richard A. Elion, MD

11:05 AM
A Timeline of HIV Treatment: Where Are We Today?
Richard A. Elion, MD

11:20 AM
Critical Appraisal of New DHHS Guidelines – Incorporating New Agents

David A. Wohl, MD

11:35 AM
Comorbidities in Patients With HIV
Grace A. McComsey, MD, FIDSA

11:55 AM
Great Debates in HIV Care: TDF Versus TAF in Patients With HIV
Moderated by Richard A. Elion, MD

12:10 PM
Case Debate I: Individualized Treatment for Patients With Newly Diagnosed HIV
Graeme J. Moyle, MD, MBBS, DipGUM

12:25 PM
Case Debate II: Managing HIV in Women – Considerations and Challenges
Grace A. McComsey, MD, FIDSA

12:40 PM
Case Debate III: Switching Regimens in Patients With HIV and Multiple Comorbidities
Babafemi O. Taiwo, MBBS

12:55 PM

1:00 PM

Learning Objectives

Upon successful completion of this activity, participants should be better able to:

  • Assess new clinical evidence about conventional and newer antiretroviral treatment regimens for HIV, including ongoing research.

  • Apply updated guidelines to improve the overall management of patients with HIV.

  • Assess the differences in safety and efficacy between tenofovir alafenamide (TAF) and tenofovir disoproxil fumarate (TDF) in antiretroviral therapeutic regimens.

  • Implement best practices to reduce risk factors and manage chronic comorbidities in patients with HIV.

  • Incorporate measures that improve the individualized management of HIV in newly diagnosed patients, women, and in those with comorbidities.

Target Audience

The intended audience for this activity is infectious disease specialists and other health care professionals involved in the treatment of patients with HIV.

This continuing medical education activity is provided by Vindico Medical Education.

This activity is supported by an educational grant from Merck & Co., Inc.

This activity is not affiliated with the official program of IDWeek™ 2019.

Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Vindico Medical Education designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all planners, teachers, and authors involved in the development of CME content are required to disclose to the accredited provider their relevant financial relationships. Relevant financial relationships will be disclosed to the activity audience.

Faculty, topics, program schedule, and credit hours are subject to change. Audiotaping or videotaping is prohibited without written permission from the program committee.

MIPS Qualifying Activity:
Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS). Participants who successfully complete the activity and its performance assessment will receive printable documentation of successful completion for MIPS self-reporting.

Share with friends

Date and Time


Marriott Marquis Washington, DC

901 Massachusetts Ave NW

Liberty Salons IJKL; Meeting Level 4

Washington, DC 20001

View Map

Save This Event

Event Saved